Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)

Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering (7), New York

Washington Hospital Center Department of Medical Oncology, Washington D.C.

Virginia Oncology Associates Viriginia Oncology Assoc., Norfolk

Duke University Medical Center Duke University Med Ctr (8), Durham

Longstreet Cancer Center, Gainesville

University Cancer & Blood Center, LLC, Athens

Kingport Hematology Oncology, Kingsport

Karmanos Cancer Institute Karmonos Cancer Instit. (40), Detroit

North Shore University Health System, Evanston

Washington University School of Medicine Center for Advanced Medicine, St Louis

MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (4), Houston

South Texas Oncology and Hematology, PA South Texas Onc/Hem, San Antonio

University of Colorado University of Colorado, Aurora

Kootenai Medical Center Kootenai Cancer Cancer, Coeur d'Alene

Southern Nevada Cancer Research Foundation S. Nevada Cancer Res (2), Las Vegas

Oregon Health & Science University OHS University, Portland

University of California San Diego - Moores Cancer Center Moores UCSD Cancer Center (31), La Jolla

Dana Farber Cancer Institute Dana-Farber, Boston

Dartmouth Hitchcock Medical Center, Lebanon

Penn State University / Milton S. Hershey Medical Center Penn Stat University, Hershey

Roger Williams Medical Center Medical Center, Providence